National Institute of Allergy and Infectious Diseases, National Institute of Health. Chronic fatigue syndrome: information for physicians (1996).
5.
Chronic fatigue syndrome. Summary of a Report of a Joint Committee of the Royal Colleges of Physicians, Psychiatrists and General Practitioners. J R Coll Physicians Lond1996; 30:497–504.
6.
Editorial. Frustrating survey of chronic fatigue. Lancet1996; 348:971.
7.
ChaudhuriABehanPO. Chronic fatigue syndrome following chronic low dose organophosphate exposure. Am J Med1997 (in press).
AchesonED. The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease and epidemic neuromyasthenia. Am J Med1959; 26:569–95
10.
GillepsieNCLewisRJPearnJH. Ciguatera in Australia: occurrence, clinical features, pathophysiology and management. Med J Aust1986; 145:584–90.
11.
CritchleyEM. Botulism and Gulf War syndrome. Lancet1996; 347:1561.
12.
BehanPOHaniffahBAG. Chronic fatigue syndrome: a possible delayed hazard of pesticide exposure. Clin Infect Dis1994; 18(suppl. 1):S54.
13.
ChesterACLevinePH. Concurrent sick building syndrome and chronic fatigue syndrome: epidemic neuromyasthenia revisited. Clin Infect Dis1994; 18(suppl 1):S43–S48.
14.
FriedbergF. The stress/fatigue link in chronic fatigue syndrome. In: KlimasNPatarcaR (eds). Clinical management of chronic fatigue syndrome. New York: Haworth Medical Press, 1996; 147–52.
15.
MacDonaldKLOsterholmMTLeDellKH. A case control study to assess possible triggers and cofactors in chronic fatigue syndrome. Am J Med1996; 100:554.
JohnsonSKDeLucaJNatelsonBH. Assessing somatization disorder in the chronic fatigue syndrome. Psychosom Med1996; 58:50–7.
25.
SaischSGNDealeAGardnerWNWesslyS. Hyperventilation and chronic fatigue syndrome. Q J Med1994; 87:63–7.
26.
BassCGardnerWN. Respiratory and psychiatric abnormalities in chronic symptomatic hyperventilation. Br Med J1985; 290:1387–90.
27.
ParsonsPE. National Health Interview Survey. Hyattsville, MD, National Centre for Health Statistics1989.
28.
BodianD. Poliomyelitis: neuropathologic observations in relation to motor symptoms. JAMA1947; 134:1269–76.
29.
BodianD. Histopathological basis of clinical findings in poliomyelitis. Am J Med1949; 6:563–78.
30.
BrunoRL. Chronic fatigue, fainting and autonomic dysfunction: further similarities between post polio fatigue and chronic fatigue syndrome?Journal of Chronic Fatigue Syndrome1997(in press).
31.
BuchwaldDKomaroffAL. Review of laboratory findings for patients with chronic fatigue syndrome. Rev Inf Dis1991; 13(Suppl 1):S12–S18.
32.
ArchardLCBehanPOBellEJ. Postviral fatigue syndrome: persistence of enterovirus RNA in muscle and elevated creatinine kinase. J R Soc Med1988; 81:326–9
33.
DuBoisRESeeleyJKBrusI. Chronic mononucleosis syndrome. South Med J1984; 77:1376–82
34.
StraussSETosatoGArmstrongG. Persisting illness and fatigue in adults with Ebstein-Barr virus infection. Ann Intern Med1985; 102:7–16.
35.
HorowitzCAHenleWHenleG. Long term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis. J Infect Dis1985; 151:1150–3.
36.
LamyMEFavartAMCornuC. Study of Epstein-Barr virus (EBV) antibodies: IgG and IgM anti-VCA, IgG anti-EA and IgG anti-EBNA obtained with an original microtiter technique; serological criterion of primary and recurrent EBV infections and follow-up of infectious mononucleosis; seroepidemiology of EBV in Belgium based on 5178 sera from patients. Acta Clin Belg1982; 37:281–98.
37.
CunninghamLBowlesNEArchardLC. Persistent viral infection of muscle in postviral fatigue syndrome. In: Behan PO, Goldberg DP, Mowbray JF (eds). Postviral fatigue syndrome. Br Med Bull1991; 47:853–71.
38.
GowJWBehanWMH. Amplification and identification of enteroviral sequences in postviral fatigue syndrome. In: Behan PO, Goldberg DP, Mowbray JF (eds). Postviral fatigue syndrome. Br Med Bull1991; 47:872–85.
39.
GowJWBehanPO. Viruses and chronic fatigue syndrome. Journal of Chronic Fatigue Syndrome1996; 2(1):67–83.
40.
GowJWde la TorreJCBehanWMH. Borna disease virus in chronic fatigue syndrome. Neurological Infections and Epidemiology1997; 2:63–6.
41.
BehanWMHMoreIARBehanPO. Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol1991; 83:61–5.
42.
ZhangCBaumerAMackayIR. Unusual pattern of mitochondrial DNA deletions in skeletal muscle of an adult human with chronic fatigue syndrome. Hum Mol Genet1995; 4:751–4.
43.
BehanWMHGowJWSimpsonK. Mitochondrial findings in chronic fatigue syndrome. J Pathol1994; 173:S17.
44.
BehanPOBehanWHMBellEJ. The postviral fatigue syndrome - an analysis of findings in 50 cases. J Infect1985; 10:211–22.
45.
ArnoldDLBorePJRaddaGK. Excessive intracellular acidosis of skeletal muscles in exercise in a patient with a postviral exhaustion fatigue syndrome. Lancet1984; I:1367–9.
46.
ArnoldDLBorePJRaddaGK. Excessive intracellular acidosis of skeletal muscle on exercise in the post-viral exhaustion/fatigue syndrome: a 31P NMR study. Proc 3rd Annual Meeting of the Society for Magnetic Resonance in Medicine, New York1984;12–13.
47.
BarnesPRJTaylorDJKempGJRaddaGK. Skeletal muscle bioenergetics in the chronic fatigue syndrome. J Neurol Neurosurg and Psychiat1993; 56:679–83.
48.
WongRLopsachukGZhuG. Skeletal muscle metabolism in chronic fatigue syndrome. In vivo assessment by 31P nuclear magnetic resonance spectroscopy. Chest1992; 102:1716–22.
49.
SoussiBScherstenTWaldenstörmARonquistG. Phosphocreatine turnover and pH balance in forearm muscles of patients with syndrome X. Lancet1993; 341:829–30.
BehanWMHHoltIJKayDHMoonieP. In vitro study of muscle oxidative metabolism in chronic fatigue syndrome. J Neurol Neurosurg Psychiat (submitted for publication).
52.
SistoSALaMancaJCorderoDL. Metabolic and cardiovascular effects of a progressive exercise test in patients with chronic fatigue syndrome. Am J Med1996; 100:634–40.
53.
LloydARGandeviaSCHalesJP. Muscle performance, voluntary activation, twitch properties and perceived effort in normal subjects and patients with the chronic fatigue syndrome. Brain1991; 114:85–98.
54.
LaneRJMBurgessAPFlintJ. Exercise responses and psychiatric disorder in chronic fatigue syndrome. Br Med J1995; 311:544–5.
55.
RileyMSO'BrienCJMcCluskeyDR. Aerobic work capacity in patients with chronic fatigue syndrome. Br Med J1990; 301:953–6.
56.
Kent-BraunJASharmaKRWeinerMW. Central basis of muscle fatigue in chronic fatigue syndrome. Neurology1993; 43:125–31.
57.
PaulLWoodLBehanWMHMacLellanW. Demonstration of delayed recovery from fatiguing exercise in chronic fatigue syndrome. Eur J Neurol (submitted).
58.
Jamal GA, Hansen S. Electrophysiological studies in the post-viral fatigue syndrome. J Neurol Neurosurg and Psychiat 1985; 48:691–4.
CostaDCBrostoffJEllPJ. Brain stem hypoperfusion in patients with myalgic encephalomyelitis chronic fatigue syndrome. (abstr) Eur J Nucl Med1992; 19:773.
63.
RosenstockLKeiferMDaniellWE. Chronic central nervous system effects of acute organophosphate pesticide intoxication. Lancet1991; 338:223–7.
64.
BidardJNVijverbergHPMFrelinC. Ciguatoxin is a novel type of Na+ channel toxin. J Biol Chem1984; 259:8353–7.
65.
DunstanRHDonohoeMTaylorWRobertsTK. A preliminary investigation of chlorinated hydrocarbons and chronic fatigue syndrome. Med J Aust1995; 163:293–7.
66.
MeschULowenthalRMColemanD. Lead poisoning masquerading as chronic fatigue syndrome. Lancet1996; 347:1193.
67.
BellIRMillerCSSchwartzGE. An olfactory-limbic model of multiple chemical sensitivity syndrome: possible relationship to kindling and affective spectrum disorders. Biol Psychiatry1991; 32:218–42.
68.
BakheitAMOBehanPOWatsonWSMortonJJ. Abnormal arginine-vasopressin secretion and water metabolism in patients with postviral fatigue syndrome. Acta Neurol Scand1993; 87:234–8.
69.
YoungJBBrownjohnAMChapmanCLeeMR. Evidence for a hypothalamic disturbance in cyclical oedema. Br Med J1983; 286:1691–3.
70.
BrunoRLCreangeSZimmermanJRFrickNM. Elevated plasma prolactin and EEG slow wave power in post-polio fatigue: Implications for a dopamine deficiency underlying chronic fatigue syndrome. Am J Med1998(in press).
71.
DemitrackMADaleJKStraussSE. Evidence for impaired activation of HPA axis in patients with chronic fatigue syndrome. J Clin Endocrin Metab1991; 73:1124–34.
72.
DinanTG. Studying brain receptor function: a neuroendocrine approach. Ir J Psychol Med1993; 10:4–5.
73.
O'KeaneVDinanTG. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotoninergic function. Am J Psychiatry1991; 148:1009–15.
74.
BakheitAMOBehanPODinanTG. Possible upregulation of hypothalamic 5–hydroxytryptamine receptors in patients with postviral fatigue syndrome. Br Med J1992; 304:1010–12.
75.
McClaveSASniderHL. Use of indirect calorimetry in clinical nutrition. Nutr Clin Pract1992; 7:207–21.
76.
FerranniniE. The theoretical basis of indirect calorimetry: a review. Metabolism1988; 37:287–301.
77.
WaldenstormARonquistGLagerqvistB. Angina pectoris patients with normal coronary angiograms but abnormal thallium perfusion scan exhibit low myocardial and skeletal muscle energy charge. J Intern Med1992; 231:327–31.
78.
WaldenstromARonquistGFolhmanJ. Ionophoric interaction with the myocyte sarcolemma: a new insight in the pathophysiology of degenerative myocardial disease. Scand J Infect Dis1993; 88:131–4.
79.
WatsonWSMcCreathGTChaudhuriABehanPO. Possible cell membrane transport defect in chronic fatigue syndrome. Journal of Chronic Fatigue Syndrome1997; 3(3):1–13.
80.
De StefanoNMatthewsPMFordB. Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology1995; 45:1193–8.
81.
WilsonAHickieILloydAWakefieldD. The treatment of chronic fatigue syndrome: science and speculation. Am J Med1994; 95:544–50.
82.
RosanoGMPetersNSLefroyD. 17–beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X. J American Coll Cardiol1996; 28:1500–5.
Lund-OlesenLHLund-OlesenK. The etiology and possible treatment of chronic fatigue syndrome. Med Hypotheses1994; 43:55–8.
85.
SharpstoneDRMurrayCPRossHM. Energy balance in asymptomatic HIV infection. AIDS1996; 10:1377–84.
86.
LiptonSA. Calcium channel antagonists and Human Immunodeficiency Virus coat -protein mediated neuronal injury. Ann Neurol1991; 31:110–14.
87.
GarryRF. Similarities of viral proteins to toxins that interact with monovalent cation channels: molecular mimicry and a possible role in cytopathogenesis. J Cell Biochem1992; S16c:129.
88.
BloomquistJR. Ion Channels as targets for insecticides. Annu Rev Entomol1996; 41:163–90.
89.
ChaudhuriAWatsonWSBehanPO. Arguments for a role of abnormal ionophore function in chronic fatigue syndrome. In: YehudaSMostofskySI (eds). Chronic fatigue syndrome. New York: Plenum Press, 1997; 119–30.